Earlier quoted context omitted.
The EU did not pay as much as the US — and signed the contracts much later. Pfizer is doing the rational actor thing and, given a shortage, prioritizing their highest paying clients. There might also be verbiage in the US contract to this effect. Also, Pfizer is an American company.
> Also, Pfizer is an American company. BioNtech is a German company. If it would come down to national egotism, BioNtech would just kill the licensing deal and Pfizer wouldn't be allowed to produce anything.
Pfizer wouldn’t be allowed to stop producing anything.